ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
맞춤형 정신의학 시장 규모는 향후 몇 년 동안 14.6%의 연평균 성장률을 기록하며 2029년에는 112억 4,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 성장의 원동력은 디지털 치료의 채택 확대, 원격 환자 모니터링에 대한 수요 증가, 코로나 사태 이후 정신건강 솔루션에 대한 수요 증가, 정신건강에 대한 정부 및 민간 부문의 투자 증가, 접근성 높은 정신건강 관리 서비스 추진 등입니다. 이 기간 동안 예상되는 주요 동향으로는 정신건강 진단에 인공지능 활용 확대, 원격 정신의학 및 온라인 진료의 인기 증가, 정신건강 데이터 보호를 위한 블록체인 통합, 치료 애플리케이션에 가상현실(VR) 활용 확대, 정신건강용 웨어러블 기기의 확대 등이 있습니다.
정신건강 문제의 유병률 증가는 맞춤형 정신의학 시장의 성장을 촉진할 것으로 예상됩니다. 정신건강 문제는 사람의 정서적, 심리적, 사회적 안녕에 영향을 미치는 광범위한 상태를 포함합니다. 이러한 문제의 증가는 스트레스 수준의 증가와 생활습관 관련 문제, 급변하는 업무 환경, 일과 삶의 균형 악화, 제한된 대처 메커니즘 등이 주요 원인으로 작용하는 경우가 많습니다. 맞춤형 정신의학은 개인별 생물학적, 심리적, 생활습관적 요인에 기반한 맞춤형 치료 계획을 제공함으로써 이러한 우려에 대응하고 있습니다. 이러한 접근 방식은 치료의 시행착오를 줄여 치료 효과를 높이고, 조기 회복과 치료 결과를 개선하는 데 도움이 됩니다. 예를 들어, 미국 국립정신건강연구소(National Institute of Mental Health)는 2022년 미국 18세 이상 성인 중 5,930만 명이 정신질환(AMI)을 앓고 있으며, 이는 전체 성인 인구의 23.1%를 차지할 것으로 추정했습니다. 따라서 정신건강 문제의 증가가 맞춤형 정신의학 시장의 성장을 주도하고 있습니다.
맞춤형 정신의학 시장의 주요 기업들은 환자 중심의 유연한 서비스 모델을 통해 맞춤형 정신의학에 대한 접근성을 개선하기 위해 맞춤형 원격 정신의학와 같은 첨단 서비스를 개발하고 있습니다. 맞춤형 원격 정신의학는 디지털 통신 플랫폼을 활용하여 개인별 유전적, 환경적, 생활습관적 요인에 기반한 맞춤형 정신의학적 평가와 치료를 제공하는 원격 정신보건 접근법입니다. 예를 들어, 2025년 4월 미국 기반의 정신건강 서비스 제공업체인 Alice's Psychiatry & Wellness는 대면 진료와 원격 정신의학 서비스를 통해 여러 주에 걸쳐 성인에게 맞춤형 정신의학를 제공하는 원격 정신건강 클리닉을 개소했습니다. 클리닉을 개설했습니다. 이 클리닉은 약리유전학적 검사를 통합하고 각 환자의 유전적 프로필에 따라 정신과 치료를 조정하여 치료 효과를 높이고 부작용을 최소화합니다. 이 클리닉은 가상 플랫폼을 활용하고 전담 의료진의 지속적인 치료를 제공함으로써 맞춤형된 정신의학 원칙에 따라 접근하기 쉽고 일관성 있고 종합적인 정신건강 지원을 보장합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 맞춤형 정신의학 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 맞춤형 정신의학 시장 : 성장률 분석
세계의 맞춤형 정신의학 시장 실적 : 규모와 성장, 2019-2024년
세계의 맞춤형 정신의학 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 맞춤형 정신의학 전체 시장(TAM)
제6장 시장 세분화
세계의 맞춤형 정신의학 시장 : 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제품
서비스
소프트웨어
세계의 맞춤형 정신의학 시장 : 기술별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
유전자 검사
인공지능
신경자극 기술
디지털 치료제
세계의 맞춤형 정신의학 시장 : 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
우울증
불안장애
양극성 장애
정신분열증
주의력결핍 과잉행동장애(ADHD)
세계의 맞춤형 정신의학 시장 : 최종사용자별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
클리닉
병원
연구기관
재택 케어
세계의 맞춤형 정신의학 시장, 제품 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
약물유전체학 검사 키트
웨어러블 디바이스
뇌 영상 장비
세계의 맞춤형 정신의학 시장, 서비스 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
원격정신과진단
개별 치료 계획
행동 평가
세계의 맞춤형 정신의학 시장, 소프트웨어 하위 세분화, 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
임상 의사결정 지원 툴
정신건강 앱
가상 테라피 플랫폼
제7장 지역별·국가별 분석
세계의 맞춤형 정신의학 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 맞춤형 정신의학 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
맞춤형 정신의학 시장 : 경쟁 구도
맞춤형 정신의학 시장 : 기업 개요
Johnson & Johnson
AbbVie Inc.
Bristol-Myers Squibb
Medtronic Plc
Takeda Pharmaceutical Company
제31장 기타 주요 기업과 혁신적 기업
Boehringer Ingelheim
Otsuka Pharmaceutical Co. Ltd.
H. Lundbeck A/S
Neurocrine Biosciences
Spring Health
Neumora Therapeutics Inc.
Atai Life Sciences
Valera Health
Compass Pathways
Genomind
Woebot Health
BrightQuest Treatment Centers
Meru Health
Alto Neuroscience
Arcara Personalized Psychiatry
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 전략
맞춤형 정신의학 시장, 2029년 : 새로운 기회를 제공하는 국가
맞춤형 정신의학 시장, 2029년 : 새로운 기회를 제공하는 부문
맞춤형 정신의학 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Personalized psychiatry is an individualized approach to mental health care that combines genetic, biological, environmental, and clinical information to customize diagnosis, treatment planning, and therapeutic strategies for each patient. This approach aims to improve treatment effectiveness, reduce adverse effects, and enable early intervention by aligning psychiatric care with the unique biological and psychological profile of the individual.
The main categories of personalized psychiatry include products, services, and software. Personalized psychiatry products consist of specialized medical tools, diagnostics, and therapeutic solutions developed to support individualized mental health treatment based on a person's genetic, biological, and behavioral traits. Key technologies in this field include genetic testing, artificial intelligence, neurostimulation technology, and digital therapeutics, which are applied in the management of conditions such as depression, anxiety disorders, bipolar disorder, schizophrenia, and attention-deficit hyperactivity disorder (ADHD). These solutions are used across various settings including clinics, hospitals, research institutes, and homecare environments.
The personalized psychiatry market research report is one of a series of new reports from The Business Research Company that provides personalized psychiatry market statistics, including personalized psychiatry industry global market size, regional shares, competitors with a personalized psychiatry market share, detailed personalized psychiatry market segments, market trends and opportunities, and any further data you may need to thrive in the personalized psychiatry industry. This personalized psychiatry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The personalized psychiatry market size has grown rapidly in recent years. It will grow from $5.69 billion in 2024 to $6.53 billion in 2025 at a compound annual growth rate (CAGR) of 14.8%. The growth during the historic period can be attributed to increased awareness of mental health, a rising prevalence of psychiatric disorders, growing demand for personalized healthcare, higher healthcare expenditures, and improved access to and affordability of healthcare services.
The personalized psychiatry market size is expected to see rapid growth in the next few years. It will grow to $11.24 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period is driven by the expanding adoption of digital therapeutics, a growing need for remote patient monitoring, increasing demand for mental health solutions in the post-COVID-19 landscape, rising government and private sector investments in mental health, and a push for more accessible mental healthcare services. Key trends expected during this period include greater use of artificial intelligence in mental health diagnostics, the rising popularity of telepsychiatry and online consultations, integration of blockchain for securing mental health data, increased use of virtual reality (VR) in therapeutic applications, and the expansion of wearable devices for mental health monitoring.
The growing prevalence of mental health issues is expected to drive the expansion of the personalized psychiatry market. Mental health issues encompass a wide range of conditions that impact a person's emotional, psychological, and social well-being. The increase in these issues is largely attributed to rising stress levels and lifestyle-related challenges, often driven by fast-paced work environments, poor work-life balance, and limited coping mechanisms. Personalized psychiatry addresses these concerns by offering tailored treatment plans based on an individual's unique biological, psychological, and lifestyle factors. This approach enhances the effectiveness of care by reducing trial and error in treatment, leading to quicker recovery and improved outcomes. For example, in 2022, the National Institute of Mental Health, a U.S.-based federal research agency, estimated that 59.3 million adults aged 18 and older in the United States had any mental illness (AMI), accounting for 23.1% of the total adult population. Therefore, the rise in mental health issues is driving the growth of the personalized psychiatry market.
Leading companies in the personalized psychiatry market are developing advanced services, such as personalized telepsychiatry, to improve access to individualized mental health care through flexible, patient-centered service models. Personalized telepsychiatry is a remote mental healthcare approach that delivers customized psychiatric evaluation and treatment based on an individual's unique genetic, environmental, and lifestyle factors using digital communication platforms. For example, in April 2025, Alice's Psychiatry & Wellness, a U.S.-based psychiatry and wellness service provider, launched a clinic to offer compassionate, personalized psychiatric care to adults across multiple states via both in-person and telepsychiatry services. This clinic integrates pharmacogenetic testing to tailor psychiatric medications according to each patient's genetic profile, enhancing treatment effectiveness and minimizing adverse effects. By leveraging virtual platforms and providing continuous care from dedicated providers, the clinic ensures accessible, consistent, and comprehensive mental health support, fully aligned with the principles of personalized psychiatry.
In March 2025, April Health Inc., a U.S.-based behavioral health company, merged with Wysa Ltd. for an undisclosed amount. This merger aims to combine Wysa's AI-driven mental health support with April Health's virtual behavioral health services, enhancing access to personalized behavioral healthcare through primary care providers. Wysa Ltd., a U.S.-based digital mental health company, utilizes artificial intelligence (AI) to deliver personalized, evidence-based psychiatric support.
Major players in the personalized psychiatry market are Johnson & Johnson, AbbVie Inc., Bristol-Myers Squibb, Medtronic Plc, Takeda Pharmaceutical Company, Boehringer Ingelheim, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Neurocrine Biosciences, Spring Health, Neumora Therapeutics Inc., Atai Life Sciences, Valera Health, Compass Pathways, Genomind, Woebot Health, BrightQuest Treatment Centers, Meru Health, Alto Neuroscience, Arcara Personalized Psychiatry, GreyBird Ventures, Mind Sync Therapeutics, Starling Minds, and HMNC Holding GmbH.
North America was the largest region in the personalized psychiatry market in 2024. The regions covered in personalized psychiatry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the personalized psychiatry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The personalized psychiatry market consists of revenues earned by entities by providing services such as remote patient monitoring services for mental health, mental health coaching programs, medication management support, lifestyle and behavioral modification programs, cognitive assessment services, and in-home psychiatric care. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized psychiatry market also includes sales of biomarker-based diagnostic assays, neurofeedback equipment, point-of-care mental health diagnostic tools, personalized supplement formulations, and biosensor-integrated monitoring tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Personalized Psychiatry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on personalized psychiatry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for personalized psychiatry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized psychiatry market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Products; Services; Software
2) By Technology: Genetic Testing; Artificial Intelligence; Neurostimulation Technology; Digital Therapeutics
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Personalized Psychiatry Market Characteristics
3. Personalized Psychiatry Market Trends And Strategies
4. Personalized Psychiatry Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Personalized Psychiatry Growth Analysis And Strategic Analysis Framework
5.1. Global Personalized Psychiatry PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Personalized Psychiatry Market Growth Rate Analysis
5.4. Global Personalized Psychiatry Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Personalized Psychiatry Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Personalized Psychiatry Total Addressable Market (TAM)
6. Personalized Psychiatry Market Segmentation
6.1. Global Personalized Psychiatry Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Products
Services
Software
6.2. Global Personalized Psychiatry Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Testing
Artificial Intelligence
Neurostimulation Technology
Digital Therapeutics
6.3. Global Personalized Psychiatry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Depression
Anxiety Disorders
Bipolar Disorder
Schizophrenia
Attention-Deficit Hyperactivity Disorder (ADHD)
6.4. Global Personalized Psychiatry Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinics
Hospitals
Research Institutes
Homecare Settings
6.5. Global Personalized Psychiatry Market, Sub-Segmentation Of Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmacogenomic Test Kits
Wearable Devices
Brain Imaging Devices
6.6. Global Personalized Psychiatry Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Telepsychiatry
Personalized Treatment Planning
Behavioral Assessment
6.7. Global Personalized Psychiatry Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical Decision Support Tools
Mental Health Apps
Virtual Therapy Platforms
7. Personalized Psychiatry Market Regional And Country Analysis
7.1. Global Personalized Psychiatry Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Personalized Psychiatry Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
